Published in Health Business Week, May 27th, 2005
Net income in the quarter was a record $11.2 million, or $0.16 per share, up 40.1% from $8.0 million or $0.12 per share, in the comparable quarter of 2004.
Martin J. Emerson, president and CEO, commented, "We are pleased with the significant first quarter growth realized worldwide across our broad product portfolio. New products contributed significantly to our fast...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.